<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00162591</url>
  </required_header>
  <id_info>
    <org_study_id>P040201 AT/AT/04-116</org_study_id>
    <nct_id>NCT00162591</nct_id>
  </id_info>
  <brief_title>Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl</brief_title>
  <official_title>Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <brief_summary>
    <textblock>
      The aim of this protocol is to study the prophylactic effect of remifentanil on bispectral
      index variation during a nociceptive stimuli.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain is difficult to estimate in ICU because most of the patients are sedated. Bispectral
      index could be helpful in detecting this pain in ICU patients. Remifentanil is a
      morphinomimetic product with short half life that could be interesting for short nociceptive
      stimuli, as bronchoalveolar lavage.

      The purpose of this study is to evaluate the impact of remifentanil infusion on bispectral
      index (BIS) variations during bronchoalveolar lavage.

      It is a prospective, double blind study, versus placebo on 40 sedated and critically ill
      patients.

      The hypothesis is that BIS can study analgesia in sedated patient.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2004</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BIS variation during bronchoalveolar lavage</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure, diastolic blood pressure, heart rate viation</measure>
  </secondary_outcome>
  <enrollment>40</enrollment>
  <condition>Pain</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>remifentanyl</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sedated patient with mechanical ventilation with suspected nosocomial pneumonia

        Exclusion Criteria:

          -  Pace maker

          -  Neurologic illness

          -  Hemodynamic instability

          -  Hypothermia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>QUINTARD H Hervé, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Surgical ICU Bichat Claude Bernard (Paris, France)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>QUINTARD h Hervé, MD</last_name>
    <phone>+33140258816</phone>
    <email>quintard@libertysurf.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Surgical ICU Bichat Claude Bernard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>QUINTARD H Hervé, MD</last_name>
      <phone>+33140258116</phone>
      <email>quintard@libertysurf.fr</email>
    </contact>
    <investigator>
      <last_name>QUINTARD H Hervé, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2004</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2005</study_first_submitted>
  <study_first_submitted_qc>September 10, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2005</study_first_posted>
  <last_update_submitted>November 21, 2005</last_update_submitted>
  <last_update_submitted_qc>November 21, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2005</last_update_posted>
  <keyword>Bispectral index</keyword>
  <keyword>sedation</keyword>
  <keyword>remifentanyl</keyword>
  <keyword>Bronchoalveolar lavage</keyword>
  <keyword>Intensive care</keyword>
  <keyword>Nociceptive stimuli</keyword>
  <keyword>Sedated patient</keyword>
  <keyword>BIS variation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

